Sponsored
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
Posted
Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son Aalok will oversee North America as COO. Richard Ascroft will take over as CEO of North America, replacing Abhay Gandhi, as Sun Pharma continues its strategic leadership evolution.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Maoist leader urges RSP to join budget debate, says visit visa demands have been addressed
KATHMANDU: CPN (Maoist Centre) deputy general secretary Barshaman Pun on Sunday called on the...
Tier 2 cities' housing slumps in Q1: Affordable supply falls 54%, says report; developers shift focus to premium housing
New Delhi sees a shift in the housing market. Affordable housing in tier 2 cities declines by 54%...